<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">The pathogenesis of SARS-Cov-2 produces severe respiratory outcomes within a few weeks of initial infection, even in the absence of preexisting respiratory comorbidities such as chronic obstructive pulmonary disease (COPD) [
 <xref ref-type="bibr" rid="CR39">39</xref>]. In half of the critically ill patients, the development of SARS-Cov-2-induced pneumonia currently results in death within 28 days of diagnosis and 7 days of admission to the intensive care unit (ICU) [
 <xref ref-type="bibr" rid="CR40">40</xref>]. Patients that require ventilators or who develop acute respiratory distress syndrome (ARDS), characterized by fluid accumulation in the alveoli, are more likely to die [
 <xref ref-type="bibr" rid="CR40">40</xref>]. Approximately 67% and 71% of critically ill patients develop ARDS or require ventilator therapy, respectively [
 <xref ref-type="bibr" rid="CR40">40</xref>].
</p>
